
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose
Publication
, Conference
Sholukh, AM; Siddappa, NB; Shanmuganathan, V; Lakhashe, SK; Rasmussen, RA; Watkins, JD; Vyas, HK; Mukhtar, MM; Hemashettar, G; Thorat, S ...
Published in: RETROVIROLOGY
September 13, 2012
Duke Scholars
Published In
RETROVIROLOGY
ISSN
1742-4690
Publication Date
September 13, 2012
Volume
9
Publisher
BIOMED CENTRAL LTD
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sholukh, A. M., Siddappa, N. B., Shanmuganathan, V., Lakhashe, S. K., Rasmussen, R. A., Watkins, J. D., … Ruprecht, R. M. (2012). Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. In RETROVIROLOGY (Vol. 9). BIOMED CENTRAL LTD.
Sholukh, A. M., N. B. Siddappa, V. Shanmuganathan, S. K. Lakhashe, R. A. Rasmussen, J. D. Watkins, H. K. Vyas, et al. “Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose.” In RETROVIROLOGY, Vol. 9. BIOMED CENTRAL LTD, 2012.
Sholukh AM, Siddappa NB, Shanmuganathan V, Lakhashe SK, Rasmussen RA, Watkins JD, et al. Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. In: RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.
Sholukh, A. M., et al. “Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose.” RETROVIROLOGY, vol. 9, BIOMED CENTRAL LTD, 2012.
Sholukh AM, Siddappa NB, Shanmuganathan V, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Mukhtar MM, Hemashettar G, Thorat S, Yoon JK, Villinger F, Novembre FJ, Landucci G, Forthal DN, Ratcliffe S, Robert-Guroff M, Polonis V, Montefiori DC, Ertl HC, Ruprecht RM. Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.

Published In
RETROVIROLOGY
ISSN
1742-4690
Publication Date
September 13, 2012
Volume
9
Publisher
BIOMED CENTRAL LTD
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences